Two years ago, Grafton learned he had stage four lung cancer. But thanks to a clinical trial at Duke funded by the National ...

“Although current evidence suggests switching completely from cigarette smoking to (vaping) reduces health risks, the ...

University of New Mexico researchers have received funding to launch an early-stage clinical trial of a vaccine engineered to ...

Health professionals and advocates shared experiences and insights on the critical importance of Black participation in ...

In a study published online July 9 in Blood Cancer Discovery, real-world outcomes are described for teclistamab, a T-cell-engaging bispecific antibody that targets multiple myeloma (MM) cells via the ...

After 12 weeks of treatment, 75% of per-protocol patients receiving 0.05% urcosimod showed greater than 80% reduction in ...

Aclaris Therapeutics Inc. (NASDAQ:ACRS) is one of the best low priced pharma stocks to buy now. On June 23, Aclaris ...

Tony Newberne is a high-risk multiple myeloma survivor. He is also a CPT, dietary manager, and patient advocate for several ...

Qureight, a techbio company accelerating drug development using its proprietary deep-learning image biomarkers and clinical ...

Britain has announced the births of the first babies born after mitochondrial donation – but a key clinical trial in Australia is yet to begin.

Karen Peterson was diagnosed with stage 1 triple-negative breast cancer that quickly returned as stage 4. Joining a clinical ...

In this video interview, Ramita Tandon, chief biopharma officer at Walgreens, discusses the operational investments required ...